Clinical Trial Update: Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment [Phase 2]

View source ↗

Summary

A Phase 2 dose-ranging trial of inhaled cannabis for acute migraine treatment has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Inhaled cannabis (cannabis)
• Tetrahydrocannabinol (THC) (tetrahydrocannabinol)

Snippet

Sponsor: University of California, San Diego | Conditions: Migraine, Cannabis | Phase 2 | Status: SUSPENDED